Table 2.
Demographic characteristics of patients who experienced outcome in 28 days after first dose of covid-19 vaccine or SARS-CoV-2 infection among vaccinated population in England from 1 December 2020 to 24 April 2021. Figures are column % (number) unless stated otherwise
| Characteristics | Thrombocytopenia | Venous thromboembolism | Arterial thrombosis | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ChAdOx1 nCoV-19 vaccine | BNT162b2 mRNA vaccine | Positive SARS-CoV-2 test | ChAdOx1 nCoV-19 vaccine | BNT162b2 mRNA vaccine | Positive SARS-CoV-2 test | ChAdOx1 nCoV-19 vaccine | BNT162b2 mRNA vaccine | Positive SARS-CoV-2 test | |||
| Total No of people with event | 1480 | 1010 | 950 | 3077 | 2054 | 4671 | 11 617 | 9473 | 4076 | ||
| Sex | |||||||||||
| Women | 47.8 (707) | 43.5 (439) | 39.5 (375) | 52.2 (1605) | 50.7 (1041) | 38.4 (1795) | 39.3 (4563) | 39.3 (3719) | 34.8 (1418) | ||
| Men | 52.2 (773) | 56.5 (571) | 60.5 (575) | 47.5 (1462) | 49.2 (1011) | 61.6 (2876) | 60.6 (7044) | 60.7 (5749) | 65.2 (2658) | ||
| Not recorded | 0 | 0 | 0 | 0.3 (10) | 0.1 (<5) | 0 | 0.1 (10) | 0.1 (5) | 0 | ||
| Mean age (SD) | 66.3 (16.0) | 73.1 (15.5) | 67.9 (16.0) | 68.8 (14.7) | 73.5 (13.8) | 63.8 (14.8) | 72.2 (12.5) | 76.7 (11.7) | 72.2 (13.5) | ||
| Age group, years | |||||||||||
| 16-29 | 2.5 (37) | 1.7 (17) | 1.8 (17) | 1.8 (54) | 1.1 (22) | 1.3 (60) | 0.1 (14) | 0.1 (5) | * | ||
| 30-39 | 4.7 (69) | 3.0 (30) | 4.0 (38) | 2.8 (87) | 1.5 (30) | 4.3 (199) | 0.6 (66) | 0.3 (32) | <30 | ||
| 40-49 | 7.7 (114) | 4.7 (47) | 7.2 (68) | 5.0 (153) | 3.7 (77) | 10.3 (482) | 2.7 (314) | 1.6 (155) | 4.5 (182) | ||
| 50-59 | 15.3 (227) | 7.6 (77) | 16.7 (159) | 13.8 (424) | 9.7 (199) | 24.2 (1131) | 13.0 (1512) | 7.7 (729) | 14.3 (583) | ||
| 60-69 | 22.9 (339) | 15.0 (152) | 20.3 (193) | 22.4 (689) | 15.1 (310) | 23.6 (1102) | 23.1 (2680) | 15.2 (1437) | 21.7 (886) | ||
| 70-79 | 26.1 (387) | 24.6 (248) | 22.4 (213) | 32.1 (987) | 28.7 (590) | 20.5 (959) | 33.3 (3871) | 26.5 (2507) | 24.8 (1010) | ||
| 80-89 | 14.9 (220) | 35.6 (360) | 21.1 (200) | 16.3 (501) | 33.0 (677) | 12.4 (580) | 18.0 (2090) | 37.9 (3592) | 24.3 (992) | ||
| ≥90 | 5.9 (87) | 7.8 (79) | 6.5 (62) | 5.9 (182) | 7.3 (149) | 3.4 (158) | 9.2 (1070) | 10.7 (1016) | 9.7 (394) | ||
| Ethnicity | |||||||||||
| White | 89.3 (1321) | 89.3 (902) | 83.2 (790) | 90.3 (2777) | 89.9 (1847) | 76.2 (3558) | 88.7 (10 310) | 89.5 (8483) | 80.4 (3279) | ||
| Indian | 2.4 (35) | 1.8 (18) | 2.9 (28) | 1.2 (38) | 1.3 (27) | 3.5 (163) | 2.4 (279) | 2.5 (233) | 4.3 (174) | ||
| Pakistani | 0.9 (13) | 1.2 (12) | 3.1 (29) | 0.6 (17) | 0.7 (15) | 2.4 (113) | 1.6 (184) | 1.3 (121) | 4.0 (163) | ||
| Bangladeshi | 0.5 (7) | <10 | 1.3 (12) | 0.3 (8) | * | 1.3 (59) | 0.4 (46) | 0.3 (29) | 1.4 (59) | ||
| Other Asian | 0.8 (12) | 1.0 (10) | 1.6 (15) | 0.3 (8) | 0.8 (16) | 1.8 (84) | 0.6 (71) | 0.6 (55) | 1.7 (69) | ||
| Black Caribbean | 0.9 (13) | 0.6 (6) | 1.1 (10) | 1.3 (39) | 0.8 (16) | 2.6 (121) | 0.7 (79) | 0.5 (49) | 1.1 (43) | ||
| Black African | 0.9 (13) | 0.5 (5) | 1.6 (15) | 0.7 (23) | 1.0 (20) | 3.1 (143) | 0.5 (60) | 0.4 (40) | 1.0 (41) | ||
| Chinese | * | * | * | * | * | 0.2 (10) | 0.1 (16) | 0.1 (13) | 0.3 (12) | ||
| Other ethnic group | 1.2 (18) | 1.2 (12) | 2.2 (21) | 1.0 (32) | 1.0 (21) | 3.4 (158) | 1.1 (122) | 1.0 (93) | 2.5 (103) | ||
| Ethnicity not recorded | 3.2 (47) | 3.7 (37) | 2.9 (28) | 4.3 (132) | 4.3 (88) | 5.6 (262) | 3.9 (450) | 3.8 (357) | 3.3 (133) | ||
BNT162b2 mRNA=Pfizer-BioNTech vaccine; ChAdOx1 nCoV-19=Oxford-AstraZeneca vaccine.
*
Cells with numbers <5 are suppressed.